• Pasithea Therapeutics will hold its annual stockholder meeting virtually on Sept. 9, 2026.
• Stockholders will vote on the election of two Class III directors, including Tiago Reis Marques and Lawrence Steinman.
• The meeting will also seek ratification of CBIZ CPAs as independent registered public accounting firm for fiscal 2026.
• Investors will vote on a reverse stock split amendment allowing a 1-for-2 to 1-for-20 consolidation, with the final ratio set by the board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-082894), on July 29, 2026, and is solely responsible for the information contained therein.